about
Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New BiocatalystsMirror-Image Packing Provides a Molecular Basis for the Nanomolar Equipotency of Enantiomers of an Experimental HerbicideTowards EMIC rational design: setting the molecular simulation toolbox for enantiopure molecularly imprinted catalystsReplication Study: BET bromodomain inhibition as a therapeutic strategy to target c-MycFree radicals, antioxidants in disease and health.Stereospecific quantitation of 6-prenylnaringenin in commercially available H. lupulus-containing natural health products and dietary supplements.Lateral chirality-sorting optical forcesA direct approach to amines with remote stereocentres by enantioselective CuH-catalysed reductive relay hydroaminationImaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties.On the origin of the stereoselective affinity of Nutlin-3 geometrical isomers for the MDM2 protein.Chromatographic Studies of Protein-Based Chiral Separations.Carbon nanotubes: applications in pharmacy and medicine.Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents.Crystal structure of {(R)-N2-[(benzo[h]quinolin-2-yl)meth-yl]-N2'-[(benzo[h]quinolin-2-yl)methyl-idene]-1,1'-binaphthyl-2,2'-di-amine-κ4N,N',N'',N'''}(trifluoromethane-sulfonato-κO)zinc(II)} trifluoromethane-sulfonate di-chloro-methane 1.5-solvate.Asymmetric 18F-fluorination for applications in positron emission tomography.Syntheses, Characterization, Resolution, and Biological Studies of Coordination Compounds of Aspartic Acid and Glycine.Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical TrialImprovement of the Process Stability of Arylmalonate Decarboxylase by Immobilization for Biocatalytic Profen Synthesis.Theoretical Investigation of the Enantioselective Complexations between pfDHFR and Cycloguanil Derivatives.The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats.Chirality of Modern Antidepressants: An Overview.Significance and challenges of stereoselectivity assessing methods in drug metabolism.Femtosecond Laser Mass Spectrometry and High Harmonic Spectroscopy of Xylene Isomers.Spontaneous enanti-omorphism in poly-phased alkaline salts of tris-(oxalato)ferrate(III): crystal structure of cubic NaRb5[Fe(C2O4)3]2.Surface-modified three-dimensional graphene nanosheets as a stationary phase for chromatographic separation of chiral drugsField detection devices for screening the quality of medicines: a systematic review
P2860
Q26752345-00B7D2CE-92FA-4281-931C-0A91F81BE555Q27728190-21CB7C00-6EDA-44A6-94D4-15FF1B98253DQ28073803-A90CAF2B-35A1-495E-9E58-2CDDFE808A2FQ28559676-4701BA68-DF9C-46E0-AC54-9A6301B60BA6Q34344766-58529B42-8801-4FF3-B3DD-E607AA073BF4Q36209902-AAB68C34-8995-4112-B76D-5C853FF8CA2CQ36238407-C52902C8-A6CB-40AC-A008-7FDAE0ED5449Q36495458-8BB4B77E-B2C0-4D6D-B1A5-F4FD11FFCC14Q37063163-DF030706-08CF-47DE-8C3B-90626392BD22Q37127629-6D28ED3C-1AA6-4770-AF6D-698CF1426817Q37525809-D4F0F14C-1798-4377-9AC6-E89AD7FAA5C0Q37718776-BE738EB0-6D65-410B-9309-F3E0C81622C9Q38160231-B57CCF7E-6697-4956-B79C-2E3688CCD577Q39091680-492A4A30-5817-451A-8229-E01FFA87B2C1Q40529090-D9B2D9A2-D436-4DB0-9191-4B72DBB262A3Q40953347-63482E92-84D2-4EC0-8EA0-6AD43849526FQ41174141-94343810-11E8-4527-85C5-A38E8A1F92BDQ41770396-FAFCA62F-4C6E-4A47-B5E1-9D67403402C6Q42284859-99E9F815-2246-4723-A5B9-B698C834D5CCQ42316132-316FDD76-674A-4A92-B307-24F88CA3C1E5Q47327607-C4F0DE97-2A8D-453B-AF7D-F52C2ECB8872Q47658516-6E333556-C317-4F87-9773-3E7F76ABF0EBQ49299197-E77CA95A-0E3D-4D40-B21C-208D8B381D61Q49538988-16AFF141-CA4B-4A4E-A716-3CB6A89A7D61Q52371375-19F6224E-71D4-4F4E-A52B-93AF3D2BB3B3Q55603651-9DA7BCF7-8843-4AE2-AAB1-7D5A2D83F060Q57041961-F3B8F328-2A2C-4C37-AAF7-8A37075799C7Q58693483-60EBA08E-7D2B-4EEC-8BDC-6FF6EBD8868A
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Chiral drugs: an overview.
@ast
Chiral drugs: an overview.
@en
Chiral drugs: an overview.
@nl
type
label
Chiral drugs: an overview.
@ast
Chiral drugs: an overview.
@en
Chiral drugs: an overview.
@nl
prefLabel
Chiral drugs: an overview.
@ast
Chiral drugs: an overview.
@en
Chiral drugs: an overview.
@nl
P2093
P2860
P1476
Chiral drugs: an overview.
@en
P2093
Chuong Pham-Huy
Lien Ai Nguyen
P2860
P304
P577
2006-06-01T00:00:00Z